Codexis, Inc. (CDXS) vs Coherus Oncology, Inc. (CHRS)
A side-by-side comparison of Codexis, Inc. and Coherus Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDXS
Codexis, Inc.
$1.42HealthcareDelayed quote: Oct 6, 2026, 11:49 AM EDT
CHRS
Coherus Oncology, Inc.
$1.07HealthcareDelayed quote: Oct 6, 2026, 11:50 AM EDT
Total return — CDXS vs CHRS
growth of $100 · dividends reinvested · last 10yCDXS -68.6% (-10.9%/yr)CHRS -95.9% (-27.3%/yr)CDXS compounded faster over this window
Log scale — wide-divergence pair
CDXS CHRS
CDXS vs CHRS: by the numbers
- •CHRS is the larger company ($165M vs $152M market cap).
- •Both run net losses; CDXS's is the smaller (-39.55% vs -257.10% net margin).
- •CDXS grew revenue faster over the past five years (0.38% vs -33.60% CAGR).
Metrics side by side
Valuation
| Metric | CDXS | CHRS |
|---|---|---|
| P/S ratio | 1.96 | 3.23 |
| P/B ratio | 4.62 | 2.70 |
Profitability
| Metric | CDXS | CHRS |
|---|---|---|
| Gross margin | 83.71% | 63.55% |
| Operating margin | -54.46% | -425.72% |
| Net margin | -39.55% | -257.10% |
| ROE | -93.22% | -215.26% |
| ROIC | -23.41% | -135.38% |
Growth (annualized)
| Metric | CDXS | CHRS |
|---|---|---|
| Revenue CAGR (5Y) | 0.38% | -33.60% |
| Total return CAGR (5Y) | -44.64% | -41.38% |
Frequently asked
- Which has grown faster, CDXS or CHRS?
- Over the past five years, CDXS grew revenue faster — CDXS at a 0.38% CAGR versus CHRS at -33.60%.
- How have CDXS and CHRS total returns compared?
- Over the past 10 years, CDXS delivered -11.05% and CHRS delivered -26.92% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.